Ascletis Pharmaceuticals
Pre-Approval PRO BETAStale Activity
No new clinical trials started in 2+ years. Activity may be declining or company may be focusing on existing programs. Last trial started: 4/18/2024
Pipeline by Phase
Therapeutic Focus
Clinical Trials (25)
A Study to Evaluate Safety of ASC40 Tablets in Patients With Moderate to Severe Acne Vulgaris
Started: 4/18/2024
A Study to Evaluate the Safety and Efficacy of ASC40 (Denifanstat) Tablets in the Treatment of Patients With Moderate to Severe Acne Vulgaris
Started: 1/23/2024
Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM
Started: 1/21/2022
Efficacy and Safety of Danoprevir/r + PR 12week Triple Therapy in Treatment Naive Non-Cirrhotic G1 CHC China III
Started: 6/1/2016
Study to Evaluate the Safety and Efficacy of ASC40 in Subjects With Moderate to Severe Acne Vulgaris
Started: 1/12/2022
A Phase II Study of Subcutaneously Injected PD-L1 Antibody ASC22 in Chronic Hepatitis B Patients
Started: 7/17/2020
Study to Evaluate Safety, Tolerance and Efficacy of ASC22 Combined With ART in Subjects With HIV
Started: 6/28/2022
Study to Evaluate Safety and Efficacy of ASC42 Combined With ETV and PEG-IFN α-2a in Subjects With HBV
Started: 1/10/2022
Efficacy and Safety of Ravidasvir + Danoprevir/r 12-week Oral Therapy in Treatment-Naive Non Cirrhotic G1 CHC Taiwan
Started: 8/1/2015
Efficacy and Safety of Ravidasvir in Combination With Danoprevir/r and Ribavirin(RBV) in Treatment-naive, Non-cirrhotic, Chronic Hepatitis C Virus Genotype1 Infected Subjects.
Started: 7/1/2017
Efficacy and Safety of Danoprevir/r + PR 12-week Triple Therapy in Treatment-Naive, Non-Cirrhotic, G1 CHC China II
Started: 1/1/2016
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC61in Subjects With Advanced Solid Tumors
Started: 8/2/2022
Study to Evaluate Safety, Tolerability, PK and the Food Effect on PK of ASC11/RTV Tablets in Healthy Subjects
Started: 1/13/2023
Study to Evaluate Safety, Tolerability, Efficacy and Pharmacokinetics of ASC10 in Mild to Moderate COVID-19 Patients
Started: 11/28/2022
Study to Evaluate Safety, Tolerability, Pharmacokinetics and the Food Effect on PK of ASC10 Tablets in Healthy Subjects
Started: 10/7/2022
Study to Evaluate Safety, Tolerability and Pharmacokinetics of ASC42 in Chinese Healthy Subjects
Started: 7/11/2021
Study to Evaluate the Effects of Itraconazole and Rifampin on the Pharmacokinetics of ASC40 in Healthy Subjects
Started: 4/4/2021
A Study of the Relative Bioavailability of ASC41 in Healthy Subjects
Started: 9/16/2020
A Study of the Pharmacokinetics of ASC09F in Healthy Subjects
Started: 11/9/2020
A Study of the Relative Bioavailability of ASC18 Tablets vs Reference Tablets in Healthy Volunteers
Started: 3/20/2020
Ascending Single-dose Study to Evaluate TVB-2640 in Chinese Healthy Subjects
Started: 4/2/2020
A Study to Evaluate the Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in China
Started: 1/15/2018
Pharmacokinetics and Safety of Ravidasvir and Danoprevir/r in Healthy Volunteers China
Started: 7/15/2016
Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in China
Started: 8/8/2017
Safety, Tolerability and Pharmacokinetics of Danoprevir/r in Healthy Volunteers China
Started: 10/1/2015